170 related articles for article (PubMed ID: 10514288)
41. Potent, long-acting bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Can J Physiol Pharmacol; 1997 Jun; 75(6):719-24. PubMed ID: 9276154
[TBL] [Abstract][Full Text] [Related]
42. Detection of bradykinin B1 receptors in rat aortic smooth muscle cells.
Schaeffer P; Laplace MC; Savi P; Prabonnaud V; Salel V; Herbert JM
Biochem Pharmacol; 2001 Feb; 61(3):291-8. PubMed ID: 11172733
[TBL] [Abstract][Full Text] [Related]
43. Correlation of secondary structures of bradykinin B1 receptor antagonists with their activity.
Miskolzie M; Gera L; Stewart JM; Kotovych G
J Biomol Struct Dyn; 2002 Feb; 19(4):585-93. PubMed ID: 11843620
[TBL] [Abstract][Full Text] [Related]
44. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
[TBL] [Abstract][Full Text] [Related]
45. Structural characterization of lipopeptide agonists for the bradykinin B2 receptor.
Giragossian C; Nardi E; Savery C; Pellegrini M; Meini S; Maggi CA; Papini AM; Mierke DF
Biopolymers; 2001 Apr; 58(5):511-20. PubMed ID: 11241222
[TBL] [Abstract][Full Text] [Related]
46. Pharmacological characterization of ligand-receptor interactions at the zebrafish bradykinin receptor.
Bromée T; Kukkonen JP; Andersson P; Conlon JM; Larhammar D
Br J Pharmacol; 2005 Jan; 144(1):11-6. PubMed ID: 15644864
[TBL] [Abstract][Full Text] [Related]
47. Human vascular kinin receptors of the B2 type characterized by radioligand binding.
Gessi S; Rizzi A; Calò G; Agnello G; Jorizzo G; Mollica G; Borea PA; Regoli D
Br J Pharmacol; 1997 Dec; 122(7):1450-4. PubMed ID: 9421294
[TBL] [Abstract][Full Text] [Related]
48. Hoe 140 and pseudo-irreversible antagonism in the rat vas deferens in vitro.
Asghar AU; Wheeldon A; Coleman RA; Bountra C; McQueen DS
Eur J Pharmacol; 2000 Jun; 398(1):131-8. PubMed ID: 10856457
[TBL] [Abstract][Full Text] [Related]
49. Antagonistic effects of novel non-peptide chlorobenzhydryl piperazine compounds on contractile response to bradykinin in the guinea-pig ileum.
Kam YL; Ro JY; Kim HJ; Choo HY
Eur J Pharmacol; 2005 Oct; 523(1-3):143-50. PubMed ID: 16226247
[TBL] [Abstract][Full Text] [Related]
50. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism.
Gera L; Fortin JP; Adam A; Stewart JM; Marceau F
J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899
[TBL] [Abstract][Full Text] [Related]
51. Characterization of a novel binding site for 125I-Tyr-D-Arg-[Hyp3,D-Phe7,Leu8]bradykinin on epithelial membranes of guinea pig ileum.
Tousignant C; Regoli D; Rhaleb NE; Jukic D; Guillemette G
Eur J Pharmacol; 1992 Mar; 225(3):235-44. PubMed ID: 1325366
[TBL] [Abstract][Full Text] [Related]
52. Characterization of receptor-mediated actions of T-kinin.
Gao X; Stewart JM; Vavrek RJ; Greenbaum LM
Biochem Pharmacol; 1993 Nov; 46(9):1607-12. PubMed ID: 8240418
[TBL] [Abstract][Full Text] [Related]
53. Kinin B2 receptor is not involved in enalapril-induced apoptosis and regression of hypertrophy in spontaneously hypertensive rat aorta: possible role of B1 receptor.
Duguay D; Der Sarkissian S; Kouz R; Ongali B; Couture R; deBlois D
Br J Pharmacol; 2004 Feb; 141(4):728-36. PubMed ID: 14744816
[TBL] [Abstract][Full Text] [Related]
54. BK2 but not BK1 receptors mediating contractile response in human umbilical arteries: role of thromboxane A2.
Tiritilli A; El Habach T; Haury L; Duret JF
Methods Find Exp Clin Pharmacol; 2004 May; 26(4):247-52. PubMed ID: 15319801
[TBL] [Abstract][Full Text] [Related]
55. New bradykinin B(2) receptor antagonists - influence of C-terminal segment modifications on their pharmacological properties.
Sleszyńska M; Kwiatkowska A; Sobolewski D; Wierzba TH; Katarzyńska J; Zabrocki J; Borovickova L; Slaninová J; Prahl A
Acta Biochim Pol; 2009; 56(4):641-8. PubMed ID: 19997652
[TBL] [Abstract][Full Text] [Related]
56. In vitro and in vivo activity of analogues of the kinin B2 receptor antagonist MEN1 1270.
Meini S; Lecci A; Carini F; Tramontana M; Giuliani S; Maggi CA; Ricci R; Fabbri G; Anichini B; Harmat N; Rizzi A; Camarda V; Regoli D; Quartara L
Can J Physiol Pharmacol; 2002 Apr; 80(4):293-302. PubMed ID: 12025964
[TBL] [Abstract][Full Text] [Related]
57. Potent, long-acting, orally-active bradykinin antagonists for a wide range of applications.
Stewart JM; Gera L; Chan DC; Whalley ET; Hanson WL; Zuzack JS
Immunopharmacology; 1997 Jun; 36(2-3):167-72. PubMed ID: 9228542
[TBL] [Abstract][Full Text] [Related]
58. Inhibition of human and rat tissue kallikreins by peptide analog antagonists of bradykinin.
Spragg J; Vavrek RJ; Stewart JM
Adv Exp Med Biol; 1989; 247B():277-81. PubMed ID: 2610073
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of the contractile action of bradykinin on isolated smooth muscle preparations by derivatives of low molecular weight peptides.
Claeson G; Fareed J; Larsson C; Kindel G; Arielly S; Simonsson R; Messmore HL; Balis JU
Adv Exp Med Biol; 1979; 120B():691-713. PubMed ID: 517262
[TBL] [Abstract][Full Text] [Related]
60. Comparative profile of novel potent bradykinin antagonists at human B1 and B2 receptors.
Burkard M; Zuzack JS; Jones S; Francis M; Whalley ET; Stewart JM; Gera L
Immunopharmacology; 1996 Jun; 33(1-3):186-90. PubMed ID: 8856146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
